Crossmark

JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement

Crossref DOI link: https://doi.org/10.1038/bmt.2017.54

Published Online: 2017-03-27

Published Print: 2017-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Snowden, J A

McGrath, E

Duarte, R F

Saccardi, R

Orchard, K

Worel, N

Kuball, J

Chabannon, C

Mohty, M
License Information

Text and Data Mining valid from 2017-03-27
More Information

Article History

Received: 28 January 2017

Accepted: 13 February 2017

First Online: 27 March 2017

Competing interests

: JAS was previously remunerated as Medical Director of JACIE. EMG is employed by the EBMT to work as JACIE Operations Manager. He has been an unpaid member of the Organisation of European Cancer Institutes Accreditation and Designation Board. RS receives a sessional payment to work as JACIE Medical Director. The remaining authors declare no conflicts of interest.

Document is current

Any future updates will be listed below